Case 2 – Advanced low-grade ovarian cancer with peritoneal implants

 

Authors

  • Annalisa Garbi Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy.
  • Maria Teresa Achilarre Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy.
  • Maria Cristina Petrella Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy.
  • Els Van Nieuwenhuysen Division of Gynecologic Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospital of Leuven, Belgium
  • Ignace Vergote Division of Gynecologic Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospital of Leuven, Belgium

DOI:

https://doi.org/10.19156/cbn.2016.0018

Keywords:

chemoresistance, cytoreductive surgery, invasive low-grade serous ovarian cancer, MEK inhibitors

Abstract

Low-grade serous carcinomas are a less common subtype of serous epithelial ovarian cancer. They differ from high-grade serous tumors in their immuno-histochemical profile, epidemiologic features, clinical behavior and molecular characteristics. This case report describes the clinical history of a young woman who underwent multiple surgical and medical treatments.

Downloads

Published

2016-07-15

How to Cite

1.
Garbi A, Achilarre MT, Petrella MC, Van Nieuwenhuysen E, Vergote I. Case 2 – Advanced low-grade ovarian cancer with peritoneal implants:  . CBN [Internet]. 2016 Jul. 15 [cited 2024 Nov. 24];4(2):48-53. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/214

Issue

Vol. 4 No. 2 (2016): July 2016

Section

Meet the expert

License

Articles published in Cancer Breaking News are distributed under the CC Attribution-NonCommercial-NoDerivatives 4.0 license, which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.